AEAnasofia Elizondo-Plazas

Anasofia Elizondo-Plazas

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anasofia Elizondo-Plazas has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Alejandro Salcido-Montenegro

    Endocrinology Division, Department of Internal Medicine, University Hospital "Dr. José E. González", Universidad Autonoma de Nuevo Leon, 64460 Monterrey, NL, Mexico

    4 shared publications
  • José Gerardo González-González

    Plataforma INVEST Medicina UANL-KER Unit Mayo Clinic (KER Unit Mexico), Universidad Autónoma de Nuevo León Facultad de Medicina, Monterrey, Mexico

    3 shared publications
  • René Rodríguez-Gutiérrez

    Plataforma INVEST Medicina UANL-KER Unit Mayo Clinic (KER Unit Mexico), Universidad Autónoma de Nuevo León Facultad de Medicina, Monterrey, Mexico

    3 shared publications
  • José Gerardo González-González

    Endocrinology Division, Department of Internal Medicine, University Hospital "Dr. José E. González", Universidad Autonoma de Nuevo Leon, 64460 Monterrey, NL, Mexico

    2 shared publications
  • Juan Montes-Villarreal

    Endocrinology Division, Department of Medicine, Hospital Universitario "Dr. José E. González", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico

    2 shared publications
  • René Rodríguez-Gutiérrez

    Endocrinology Division, Department of Medicine, Hospital Universitario "Dr. José E. González", Universidad Autonoma de Nuevo Leon, Monterrey, Nuevo Leon, Mexico

    2 shared publications

Latest Publications

  • Open Access

    Expanding the phenotype of MTOR -related disorders and the Smith-Kingsmore syndrome

    by Anasofia Elizondo-Plazas, Marisol Ibarra-Ramírez, Azalea Garza-Báez, Laura Elia Martínez-De-Villarreal

    Heterozygous germline mutations in mammalian target of rapamycin (MTOR) (OMIM 601231) are known to underlie Smith-Kingsmore syndrome (SKS; OMIM 616638), an infrequent entity with autosomal dominant inheritance, also known as macrocephalyintellectual disability-neurodevelopmental disorder-small thorax syndrome (ORPHA 457485). 1 Among the clinical features of SKS, the most common features include intellectual disability, macrocephaly, epilepsy, and facial dysmorphism. The aim of this case is to raise awareness of a distinct phenotypical presentation of SKS manifesting with bilateral cataracts and no history of seizures.


  • Open Access

    Hypertriglyceridemia and Its Association with HbA1c Test: A ProspectiveIn VivoControlled Study

    by Rene Rodriguez-Gutierrez, Leonardo G. Mancillas-Adame, Giselle Rodríguez-Tamez, Alejandro Diaz Gonzalez-Colmenero, Ricardo Cesar Solis-Pacheco, Ana Sofia Elizondo-Plazas, Karla M. Santos-Santillana, Linda Gonzalez-Sariñana, Victoria Gonzalez-Nava, José Gerardo Gonzalez-Gonzalez

    Background. Hypertriglyceridemia and hyperglycemia coexist in 30-60% of patients with diabetes. The impact of hypertriglyceridemia regarding HbA1c assay reliability remains uncertain. Therefore, we conducted a prospectivein vivocontrolled study with the aim of defining the association between triglyceride levels and HbA1c.Methods. A total of 44 patients with an index-hospital admission diagnosis of diabetic ketoacidosis or hypertriglyceridemia-induced pancreatitis, as a model for acute elevation of triglycerides, were recruited. Blood samples were drawn for the measurement of HbA1c, triglycerides, glucose, and hemoglobin at baseline and subsequently 24 and 48 hours after admission. HbA1c analysis was performed with high-performance liquid chromatography Bio-Rad D10 (NGSP approved).Results. All patients completed the study protocol. A difference between mean triglycerides from day 0 (baseline) to day 2 of 1567.2 mg/dL was observed. We found a difference between mean serum HbA1c from days 0 to 2 of 0.09% [1 mmol/mol] (p=0.004). Moreover, a weak correlation between the mean difference of HbA1c and triglycerides from baseline to day 2 was found to be statistically significant (r=0.256,p=0.015). None of these findings, however, are clinically significant.Conclusion. Triglycerides do not impair the interpretation of HbA1c assay. Patients and clinicians can now be confident that hypertriglyceridemia is not an important factor when interpreting HbA1c results.


  • Open Access

    Sheehan’s Syndrome Revisited: Underlying Autoimmunity or Hypoperfusion?

    by José Gerardo González-González, Omar David Borjas-Almaguer, Alejandro Salcido-Montenegro, Anasofia Elizondo-Plazas, Roberto Montes-De-Oca-Luna, René Rodríguez-Gutiérrez

    Sheehan’s syndrome remains a frequent obstetric complication with an uncertain pathophysiology. We aimed to assess the incidence of hypopituitarism (≥2 hormonal axis impairment) within the first six postchildbirth months and to determine the existence of anti-pituitary antibodies. From 2015 to 2017, adult pregnant women, who developed moderate to severe postpartum hemorrhage (PPH), were consecutively included in the study. Pituitary function was assessed 4 and 24 weeks after PPH. At the end of the study, anti-pituitary antibodies were assessed. Twenty women completed the study. Mean age was 26.35 (±5.83) years. The main etiology for severe PPH was uterine atony (65%) which resulted mostly in hypovolemic shock grades III-IV. Within the first four weeks after delivery, 95% of patients had at least one hormonal pituitary affected and 60% of the patients fulfilled diagnostic criteria for hypopituitarism. At the end of the study period, five patients (25%) were diagnosed with hypopituitarism (GH and cortisol axes affected). Anti-pituitary antibodies were negative in all patients. At 6 months follow-up, one in every four women with a history of moderate-to-severe PPH was found with asymptomatic nonautoimmune-mediated hypopituitarism. The role of autoimmunity in Sheehan’s syndrome remains uncertain. Further studies are needed to improve the remaining knowledge gaps.


  • Open Access

    Acanthosis nigricans in the knuckles: An early, accessible, straightforward, and sensitive clinical tool to predict insulin resistance

    by Gloria González-Saldivar, René Rodríguez-Gutiérrez, Andrés Marcelo Treviño-Alvarez, Minerva Gómez-Flores, Juan Montes-Villarreal, Neri Alejandro Álvarez-Villalobos, Anasofía Elizondo-Plazas, Alejandro Salcido-Montenegro, Jorge Ocampo-Candiani, José Gerardo González-González

    Any clinical/biochemical marker revealing obesity or diabetes before their appearance is valuable. Insulin resistance (IR) is present in both disorders many years before occurrence. Accordingly, we determined whether acanthosis nigricans (AN) in the knuckles is associated to higher insulin and homeostasis model assessment for estimated insulin resistance (HOMA-IR) index values, and assessed the influence of body-mass index (BMI) and the diagnostic performance of AN in the knuckles to detect IR. In this cross-sectional controlled study, we included men or women, 18 to 23 years old, with or without AN in the knuckles. In 149 cases with AN in the knuckles and 145 controls, fasting insulin was higher in cases (13.45 µU/mL ± 7.8 vs. 8.59 µU/mL ± 3.63, P < .001, respectively). Mean HOMA-IR index was also higher (2.86 ± 1.68 vs. 1.78 ± 0.77, P < .001). A significant increase in fasting insulin and HOMA-IR values between and within BMI groups from normal through obese category was identified in controls and cases. By multivariate regression analysis, cases with normal BMI were significantly associated to a HOMA-IR ≥2.5 (OR = 3.09, CI95% = 1.75–5.48, P = .001). A model of AN in the knuckles, normal BMI, and increased waist circumference allowed identifying 2 out of 3 cases with HOMA-IR index ≥2.5. AN in the knuckles could be addressed with two aims: as an easy, accessible, and costless diagnostic tool suggesting hyperinsulinemia secondary to IR, and, an early marker of IR even in the absence of overweight or obesity.


  • Challenges in Choosing a Medication for Type 2 Diabetes

    by Rene Rodríguez-Gutiérrez, Alejandro Salcido-Montenegro, Anasofia Elizondo-Plazas, José Gerardo González-González


  • Metformin Use and Vitamin B12 Deficiency: Untangling the Association

    by René Rodríguez-Gutiérrez, Juan Montes-Villarreal, Karla Victoria Rodríguez-Velver, Camilo González-Velázquez, Alejandro Salcido-Montenegro, Anasofia Elizondo-Plazas, José Gerardo González-González